No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Sanofi Could Be Guilty Of Failing To Disclose the potential presence of N-Nitrosodimethylamine (NDMA) in Zantac

Plaintiff claims that Zantac causes cancer could be bolstered when the federal investigation concludes

Tuesday, January 5, 2021 - People with cancer that have used Zantac regularly and for a few years are filing lawsuits against Sanofi, the maker of the all-time best-selling heartburn and acid reflux medicine. The first bellwether Zantac cancer trials are scheduled to start in 2021. Zantac was available over the counter and by prescription until April 1, 2020, when the Food and Drug Administration (FDA) banned all types of ranitidine generic and brand. Sanofi allegedly knew about the possibility that NDMA could accelerate when stored under high temperatures or another stimulus and failed to warn consumers. The Department of Justice is investigating what executives at the company knew and when they knew it about NDMA contamination. NDMA is a naturally-occurring substance and a by-product of industrial production found in the air, water, and land around manufacturing plants in levels, however, that are assumed to be safe. The FDA placed a threshold of 96 ng per ranitidine as being the safe limit but online drug testing pharmacy Valisure found levels of NDMA orders of magnitude above the limits. N-Nitrosodimethylamine (NDMA) contamination could also have occurred due to interacting with nitrates in the stomach or at the drug's manufacturing source overseas in China and India.

It seems that the federal investigation into Sanofi's lying about what they knew affects all companies involved in the Zantac manufacturing process. According to Legal Examiner, "In one of the latest developments following the U.S. Food & Drug Administration's recall of Zantac products, the Department of Justice is reportedly investigating two of the drug's primary manufacturers for possible violations of the False Claims Act." The Examiner continues to say, "according to FiercePharma, the DOJ is now looking into whether the manufacturers knowingly failed to disclose information relating to the impurity." A Zantac cancer attorney offer a free consultation and can help people affected by stomach cancer that took Zantac as a heartburn medication and developed stomach cancer as a result.

Sanofi's half-year financial report list ongoing investigation against the company that could have an unpredictable outcome. The company is accused by government authorities of violating the New Mexico Unfair Practices Act, and the Federal False Claims Act.

According to Sanofi's report, "In June 2020, the New Mexico Attorney General filed a complaint against Sanofi, a dozen generic manufacturers, and several retailers for alleged violations of the New Mexico Unfair Practices Act, violations of the New Mexico False Advertising Act, violations of the New Mexico Public Nuisance Statute, common law public nuisance, and negligence. On June 6, 2020, Sanofi received a notice from the US Department of Justice Civil Division and US Attorney's Office for the Eastern District of Pennsylvania of an investigation into allegations that pharmaceutical manufacturers violated the False Claims Act, about the drug Zantac and ranitidine hydrochloride through alleged failure to disclose to the federal government information about the potential presence of N-Nitrosodimethylamine (NDMA)."

If you or a loved one have developed stomach, bladder, esophageal, or another type of cancer and has taken Zantac regularly for more than one year, you may wish to speak with a Zantac Cancer Lawyer.

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.